| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |